Earnings from Danaher and Sherwin-Williams

We had two more earnings reports this morning. Let’s start with Danaher (DHR). The company reported Q4 earnings of $2.08 per share. That beat Wall Street’s forecast of $1.87 per share. For the full year, Danaher made $6.31 per share on revenues of $22.3 billion.

For Q1, Danaher sees revenue growth “in the mid to high-teens range.” For all of 2021, the company expects revenue growth “in the low-double digit range.”

Rainer M. Blair, President and CEO, said, “For the full year 2020, we achieved nearly 10% core revenue growth including Cytiva, strong margin expansion, and more than $5 billion of free cash flow.”

Also this morning, Sherwin-Williams (SHW) reported Q4 earnings of $5.09 per share. Wall Street had been expecting $4.85 per share. For the year, Sherwin made $24.58 per share.

Commenting on the financial results, John G. Morikis , Chairman and Chief Executive Officer, said, “We finished the year strong in the fourth quarter driven by 9% U.S. and Canada same store sales growth, continued North American DIY growth and growth in all industrial end markets. My deepest thanks goes to our 61,000 employees who delivered outstanding results in what was an extremely challenging and unpredictable year. For the full year, we delivered record sales, EBITDA and EPS, and we generated over $3.4 billion in net operating cash, which enabled us to return over $2.9 billion to shareholders via dividends and share repurchases. Each of our segments delivered improved segment profit and margin in 2020.

For Q1, Sherwin expects that “sales will increase high single digits.” For the whole year, the company expects “sales to increase mid-to-high single digits.”

Sherwin sees full-year earnings ranging between $26.40 and $27.20 per share.

Posted by on January 28th, 2021 at 11:20 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.